Last reviewed · How we verify

NCT04663113

Investigation of the Effect of Exercise Protocol Determined According to Metabolic Rate in Early Burn Patients on Coagulation, Fibrinolytic Activity and Functional Capacity

Completed NA Last updated 12 April 2022
What this trial tests

NA trial testing Control Group/1st group ( standard physiotherapy in Burns in 25 participants. Completed in 1 June 2021.

Timeline
15 November 2020
Primary endpoint
1 May 2021
1 June 2021

Quick facts

Lead sponsorHasan Kalyoncu University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment25
Start date15 November 2020
Primary completion1 May 2021
Estimated completion1 June 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hasan Kalyoncu University

Who can join

Adults 18 to 65, any sex, with Burns. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is; To investigate the Effect of the Exercise Protocol Determined According to Metabolic Rate in Early Burn Patients on Coagulation, Fibrinolytic Activity and Functional Capacity, and to create an exercise protocol that can guide researchers working in burn patients and physiotherapists working in burn centers at national and international level. The study, which is planned to be carried out in Hasan Kalyoncu University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation, will be included in the burn patients in the 25 Aralık State Hospital Burn Center, service and intensive care unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Burns

Currently open trials in the same condition.

Other Hasan Kalyoncu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04663113.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing